Skip to main content
icon for Weed reagendado por...?
Política·Trump

Weed reagendado por...?

icon for Weed reagendado por...?
Política·Trump

Weed reagendado por...?

mar 31

mar 31

$757,498 Vol.

31 mar 2026
Polymarket

$757,498 Vol.

Polymarket

30 de junho

$336,125 Vol.

3%

31 de dezembro

$156,491 Vol.

28%

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.DEA's April 2026 final order rescheduling FDA-approved cannabis products like Epidiolex and state-licensed medical marijuana to Schedule III eased restrictions such as Section 280E taxes for compliant operators but left recreational cannabis and broader marijuana in Schedule I, explaining traders' low 3% odds for full rescheduling by June 30. The expedited administrative hearing starting June 29 will build an evidentiary record for potential wider changes, boosting 26% implied probability by December 31 amid procedural timelines, litigation risks, and forthcoming IRS guidance. Cannabis companies including Verano are submitting DEA registrations, while congressional Democrats urge Attorney General Pam Bondi for faster action following President Trump's prior executive order on medical research.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$757,498
Data de Término
31 mar 2026
Mercado Aberto
Feb 7, 2026, 5:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.DEA's April 2026 final order rescheduling FDA-approved cannabis products like Epidiolex and state-licensed medical marijuana to Schedule III eased restrictions such as Section 280E taxes for compliant operators but left recreational cannabis and broader marijuana in Schedule I, explaining traders' low 3% odds for full rescheduling by June 30. The expedited administrative hearing starting June 29 will build an evidentiary record for potential wider changes, boosting 26% implied probability by December 31 amid procedural timelines, litigation risks, and forthcoming IRS guidance. Cannabis companies including Verano are submitting DEA registrations, while congressional Democrats urge Attorney General Pam Bondi for faster action following President Trump's prior executive order on medical research.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$757,498
Data de Término
31 mar 2026
Mercado Aberto
Feb 7, 2026, 5:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

Cuidado com os links externos.

Frequently Asked Questions

"Weed reagendado por...?" is a prediction market on Polymarket with 3 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "31 de dezembro" at 28%, followed by "30 de junho" at 3%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 28¢ implies that the market collectively assigns a 28% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Weed reagendado por...?" has generated $757.5K in total trading volume since the market launched on Nov 5, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Weed reagendado por...?," browse the 3 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Weed reagendado por...?" is "31 de dezembro" at 28%, meaning the market assigns a 28% chance to that outcome. The next closest outcome is "30 de junho" at 3%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Weed reagendado por...?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.